Ababneh NA, Scaber J, Flynn R, Douglas A, Barbagallo P, Candalija A, Turner MR, Sims D, Dafinca R, Cowley SA (2020) Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair. Hum Mol Genet 29(13):2200–2217
Article CAS PubMed PubMed Central Google Scholar
Altae-Tran H, Kannan S, Demircioglu FE, Oshiro R, Nety SP, McKay LJ, Dlakić M, Inskeep WP, Makarova KS, Macrae RK, Koonin EV, Zhang F (2021) The widespread IS200/605 transposon family encodes diverse programmable RNA-guided endonucleases. Science. https://doi.org/10.1126/science.abj6856
Article PubMed PubMed Central Google Scholar
Amoasii L, Long C, Li H, Mireault AA, Shelton JM, Sanchez-Ortiz E, McAnally JR, Bhattacharyya S, Schmidt F, Grimm D, Hauschka SD, Bassel-Duby R, Olson EN (2017) Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aan8081
Article PubMed PubMed Central Google Scholar
Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576(7785):149–157
Article CAS PubMed PubMed Central Google Scholar
Anzalone AV, Koblan LW, Liu DR (2020) Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol 38(7):824–844
Article CAS PubMed Google Scholar
Bailus BJ, Pyles B, McAlister MM, O’Geen H, Lockwood SH, Adams AN, Nguyen JT, Yu A, Berman RF, Segal DJ (2016) Protein delivery of an artificial transcription factor restores widespread Ube3a expression in an Angelman Syndrome mouse brain. Mol Therapy 24(3):548–555. https://doi.org/10.1038/mt.2015.236
Batra R, Nelles DA, Pirie E, Blue SM, Marina RJ, Wang H, Chaim IA, Thomas JD, Zhang N, Nguyen V, Aigner S, Markmiller S, Xia G, Corbett KD, Swanson MS, Yeo GW (2017) Elimination of toxic microsatellite repeat expansion RNA by RNA-targeting Cas9. Cell 170(5):899–912. https://doi.org/10.1016/j.cell.2017.07.010
Article CAS PubMed PubMed Central Google Scholar
Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ (2010) Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6–17 years. Paediatr Child Health 4(4):375–381
Bortesi L, Fischer R (2015) The CRISPR/Cas9 system for plant genome editing and beyond. Biotechnol Adv 33(1):41–52. https://doi.org/10.1016/j.biotechadv.2014.12.006
Article CAS PubMed Google Scholar
Brandt L, Bschor T, Henssler J, Muller M, Hasan A, Heinz A, Gutwinski S (2020) Antipsychotic withdrawal symptoms: a systematic review and meta-analysis. Front Psychiatry 11:569912. https://doi.org/10.3389/fpsyt.2020.569912
Article PubMed PubMed Central Google Scholar
Cai Y, Cheng T, Yao Y, Li X, Ma Y, Li L, Zhao H, Bao J, Zhang M, Qiu Z, Xue T (2019) In vivo genome editing rescues photoreceptor degeneration via a Cas9/RecA-mediated homology-directed repair pathway. Sci Adv. https://doi.org/10.1126/sciadv.aav3335
Article PubMed PubMed Central Google Scholar
Calsolaro V, Antognoli R, Okoye C, Monzani F (2019) The use of antipsychotic drugs for treating behavioral symptoms in Alzheimer’s disease. Front Pharmacol 10:1465
Article CAS PubMed PubMed Central Google Scholar
Chamberlain K, Riyad JM, Weber T (2016) Expressing transgenes that exceed the packaging capacity of adeno-associated virus capsids. Hum Gene Ther Methods 27(1):1–12
Article CAS PubMed PubMed Central Google Scholar
Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK, Vakulskas CA, Collingwood MA, Zhang L, Bode NM, Behlke MA, Dejene B, Cieniewicz B, Romano R, Lesch BJ, Gomez-Ospina N, Mantri S, Pavel-Dinu M, Weinberg KI, Porteus MH (2019) Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med 25(2):249–254. https://doi.org/10.1038/s41591-018-0326-x
Article CAS PubMed PubMed Central Google Scholar
Chen X, Pan W (2014) The treatment strategies for neurodegenerative diseases by integrative medicine. J Integr Med 1(4):223–225
Chen H, Choi J, Bailey S (2014) Cut site selection by the two nuclease domains of the Cas9 RNA-guided endonuclease. J Biol Chem 289(19):13284–13294. https://doi.org/10.1074/jbc.M113.539726
Article CAS PubMed PubMed Central Google Scholar
Chylinski K, Makarova KS, Charpentier E, Koonin EV (2014) Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res 42(10):6091–6105. https://doi.org/10.1093/nar/gku241
Article CAS PubMed PubMed Central Google Scholar
Colasante G, Qiu Y, Massimino L, Di Berardino C, Cornford JH, Snowball A, Weston M, Jones SP, Giannelli S, Lieb A, Schorge S, Kullmann DM, Broccoli V, Lignani G (2020) In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy. Brain 143(3):891–905. https://doi.org/10.1093/brain/awaa045
Article PubMed PubMed Central Google Scholar
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA (2013) Multiplex genome engineering using CRISPR/Cas systems. J Sci 339(6121):819–823
Cui J, Rothstein M, Bennett T, Zhang P, Xia N, Reijo Pera RA (2016) Quantification of dopaminergic neuron differentiation and neurotoxicity via a genetic reporter. Sci Rep 6(1):25181. https://doi.org/10.1038/srep25181
Article CAS PubMed PubMed Central Google Scholar
Dabrowska M, Olejniczak M (2020) Gene therapy for Huntington’s disease using targeted endonucleases. In: Trinucleotide repeats. Springer, pp 269–284
di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A (2019) Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson’s disease. Stem Cell Rep 12(2):213–229. https://doi.org/10.1016/j.stemcr.2018.12.011
Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096. https://doi.org/10.1126/science.1258096
Article CAS PubMed Google Scholar
Duan W, Guo M, Yi L, Liu Y, Li Z, Ma Y, Zhang G, Liu Y, Bu H, Song X, Li C (2020) The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model. Gene Ther 27(3–4):157–169. https://doi.org/10.1038/s41434-019-0116-1
Article CAS PubMed Google Scholar
Duarte F, Deglon N (2020) Genome editing for CNS disorders. Front Neurosci. https://doi.org/10.3389/fnins.2020.579062
Article PubMed PubMed Central Google Scholar
Ekman FK, Ojala DS, Adil MM, Lopez PA, Schaffer DV, Gaj T (2019) CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington’s disease mouse model. Mol Ther Nucleic Acids 17:829–839
Article CAS PubMed PubMed Central Google Scholar
Feigin VL, Vos T (2019) Global burden of neurological disorders: from global burden of disease estimates to actions. Neuroepidemiology 52(1–2):1–2. https://doi.org/10.1159/000495197
Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentino FS, Parmeggiani F (2011) Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics 12(4):238–249. https://doi.org/10.2174/138920211795860107
Article CAS PubMed PubMed Central Google Scholar
Figley SA, Liu Y, Karadimas SK, Satkunendrarajah K, Fettes P, Spratt SK, Lee G, Ando D, Surosky R, Giedlin M, Fehlings MG (2014) Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury. PLoS ONE 9(5):e96137. https://doi.org/10.1371/journal.pone.0096137
Article CAS PubMed PubMed Central Google Scholar
Gaj T, Ojala DS, Ekman FK, Byrne LC, Limsirichai P, Schaffer DV (2017) In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci Adv. https://doi.org/10.1126/sciadv.aar3952
Article PubMed PubMed Central Google Scholar
Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159(3):647–661. https://doi.org/10.1016/j.cell.2014.09.029
Article CAS PubMed PubMed Central Google Scholar
Ginestal-López RC (2018) Immunotherapy for neurological diseases, present and future. Farm 42(6):251–260
György B, Lööv C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C, Kastanenka K, Mu D, Volak A, Giedraitis V (2018) CRISPR/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer’s disease. Mol Ther Nucleic Acids 11:429–440
Article PubMed PubMed Central Google Scholar
Haenfler JM, Skariah G, Rodriguez CM, Monteiro da Rocha A, Parent JM, Smith GD, Todd PK (2018) Targeted reactivation of FMR1 transcription in fragile X syndrome embryonic stem cells. Front Mol Neurosci 11:282. https://doi.org/10.3389/fnmol.2018.00282
Article CAS PubMed PubMed Central Google Scholar
Heidenreich M, Zhang F (2016) Applications of CRISPR–Cas systems in neuroscience. Nat Rev Neurosci 17(1):36–44
留言 (0)